Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures.
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
PTH was studied for its effects on bone formation in cultured rat calvariae. 0.01-10 nM PTH stimulated [3H]thymidine incorporation into DNA by up to 4.8-fold. Although continuous treatment with PTH for 24-72 h inhibited [3H]proline incorporation into collagen, transient (24 h) treatment enhanced [3H]proline incorporation into collagen 24-48 h after the hormone was removed. The collagen stimulated by PTH was type I and the effect was observed in the periosteum-free bone and was not blocked by hydroxyurea. Furthermore, treatment with 1-100 nM PTH for 24 h increased insulin-like growth factor (IGF) I concentrations by two to fourfold, and an IGF I antibody prevented the PTH stimulation of collagen synthesis, but not its mitogenic effect. In conclusion, continuous treatment with PTH inhibits calvarial collagen, whereas transient treatment stimulates collagen synthesis, and the stimulatory effect is mediated by local production of IGF I.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peterkofsky, B., & Diegelmann, R. (1971) · Biochemistry · doi:10.1021/bi00782a009 · Cited by 1,379
TAM, C. S., HEERSCHE, J. N. M., MURRAY, T. M., & PARSONS, J. A. (1982) · Endocrinology · doi:10.1210/endo-110-2-506 · Cited by 612
Centrella, M., McCarthy, T. L., & Canalis, E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61587-x · Cited by 611
Self-citationGrowth factors and the regulation of bone remodeling.
Canalis, E., McCarthy, T., & Centrella, M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113318 · Cited by 602
Self-citationInsulin-Like Growth Factor I Has Independent Effects on Bone Matrix Formation and Cell Replication*
HOCK, J. M., CENTRELLA, M., & CANALIS, E. (1988) · Endocrinology · doi:10.1210/endo-122-1-254 · Cited by 597
Self-citationThe estimation of two collagens from human dermis by interrupted gel electrophoresis
Sykes, B., Puddle, B., Francis, M., & Smith, R. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(76)80180-5 · Cited by 560
Bone Resorption in Tissue Culture. Factors Influencing the Response to Parathyroid Hormone *
Raisz, L. G. (1965) · Journal of Clinical Investigation · doi:10.1172/jci105117 · Cited by 391
Effect of insulinlike growth factor I on DNA and protein synthesis in cultured rat calvaria.
Canalis, E. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109908 · Cited by 386
Self-citationPeterkofsky, B. (1972) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(72)90221-4 · Cited by 373
Wong, G. L., & Cohn, D. V. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.3167 · Cited by 351
Cited by
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Self-citationMechanotransduction and the functional response of bone to mechanical strain
Duncan, R. L., & Turner, C. H. (1995) · Calcified Tissue International · doi:10.1007/bf00302070 · Cited by 1,048
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & Canalis, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 914
Self-citationOhlsson, C., Bengtsson, B.-A., Isaksson, O. G. P., Andreassen, T. T., & Slootweg, M. C. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0324 · Cited by 855
The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
Finkelstein, J. S., Hayes, A., Hunzelman, J. L., Wyland, J. J., Lee, H., & Neer, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035725 · Cited by 829
The Prevention and Treatment of Osteoporosis
Wood, A. J. J., Riggs, B. L., & Melton, L. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208273270908 · Cited by 754
Sampath, T. K., Maliakal, J. C., Hauschka, P. V., Jones, W. K., Sasak, H., Tucker, R. F., White, K. H., Coughlin, J. E., Tucker, M. M., & Pang, R. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88709-4 · Cited by 678
Mechanisms of Anabolic Therapies for Osteoporosis
Canalis, E., Giustina, A., & Bilezikian, J. P. (2007) · New England Journal of Medicine · doi:10.1056/nejmra067395 · Cited by 668
Self-citationBonadio, J., Smiley, E., Patil, P., & Goldstein, S. (1999) · Nature Medicine · doi:10.1038/10473 · Cited by 650
A comprehensive overview on osteoporosis and its risk factors
Pouresmaeili, F., Kamali Dehghan, B., Kamarehei, M., & Yong Meng, G. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s138000 · Cited by 597
Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Chotiyarnwong, P., & McCloskey, E. V. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0341-0 · Cited by 489
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., Rogol, A. D., Lovejoy, J. C., Sheffield-Moore, M., Mauras, N., & Bowers, C. Y. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0038 · Cited by 452
Bone marrow mesenchymal stem cells and TGF-β signaling in bone remodeling
Crane, J. L., & Cao, X. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70050 · Cited by 448
Primary Hyperparathyroidism and the Risk of Fracture: A Population-Based Study
Khosla, S., Melton, L. J., Wermers, R. A., Crowson, C. S., O'Fallon, W. M., & Riggs, B. L. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.10.1700 · Cited by 416
Transforming growth factor‐β in stem cells and tissue homeostasis
Xu, X., Zheng, L., Yuan, Q., Zhen, G., Crane, J. L., Zhou, X., & Cao, X. (2018) · Bone Research · doi:10.1038/s41413-017-0005-4 · Cited by 414
Mechanisms of Glucocorticoid Action in Bone
CANALIS, E., & DELANY, A. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04204.x · Cited by 406
Self-citationHruska, K. A., & Teitelbaum, S. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507203330307 · Cited by 404
Hock, J. M., & Gera, I. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070110 · Cited by 367
ERNST, M., HEATH, J. K., & RODAN, G. A. (1989) · Endocrinology · doi:10.1210/endo-125-2-825 · Cited by 364
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
Ishizuya, T., Yokose, S., Hori, M., Noda, T., Suda, T., Yoshiki, S., & Yamaguchi, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119491 · Cited by 349
Parathyroid hormone-dependent signaling pathways regulating genes in bone cells
Swarthout, J. T., D'Alonzo, R. C., Selvamurugan, N., & Partridge, N. C. (2002) · Gene · doi:10.1016/s0378-1119(01)00798-3 · Cited by 340
MCCARTHY, T. L., CENTRELLA, M., & CANALIS, E. (1989) · Endocrinology · doi:10.1210/endo-124-3-1247 · Cited by 336
Self-citationEffect of GH/IGF-1 on Bone Metabolism and Osteoporsosis
Locatelli, V., & Bianchi, V. E. (2014) · International Journal of Endocrinology · doi:10.1155/2014/235060 · Cited by 307
Lieberman, J. R., Le, L. Q., Wu, L., Finerman, G. A. M., Berk, A., Witte, O. N., & Stevenson, S. (1998) · Journal of Orthopaedic Research · doi:10.1002/jor.1100160309 · Cited by 306
PTH and PTHrP signaling in osteoblasts
Datta, N. S., & Abou-Samra, A. B. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.02.012 · Cited by 295
Nakajima, A., Shimoji, N., Shiomi, K., Shimizu, S., Moriya, H., Einhorn, T. A., & Yamazaki, M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.11.2038 · Cited by 274
Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover
Ogata, N., Chikazu, D., Kubota, N., Terauchi, Y., Tobe, K., Azuma, Y., Ohta, T., Kadowaki, T., Nakamura, K., & Kawaguchi, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9017 · Cited by 271
Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
Finkelstein, J. S., Wyland, J. J., Lee, H., & Neer, R. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1703 · Cited by 265
Bikle, D. D., Sakata, T., Leary, C., Elalieh, H., Ginzinger, D., Rosen, C. J., Beamer, W., Majumdar, S., & Halloran, B. P. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.9.1570 · Cited by 259
Grinspoon, S. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.3864 · Cited by 258
Akt1 in Osteoblasts and Osteoclasts Controls Bone Remodeling
Kawamura, N., Kugimiya, F., Oshima, Y., Ohba, S., Ikeda, T., Saito, T., Shinoda, Y., Kawasaki, Y., Ogata, N., Hoshi, K., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001058 · Cited by 258
Locklin, R. M., Khosla, S., Turner, R. T., & Riggs, B. L. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10490 · Cited by 219
Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells.
MCCARTHY, T. L., CENTRELLA, M., & CANALIS, E. (1990) · Endocrinology · doi:10.1210/endo-126-3-1569 · Cited by 204
Self-citationMazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
Mechanisms of glucocorticoid-induced osteoporosis.
Canalis, E. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200307000-00013 · Cited by 164
Self-citationKostenuik, P. J., Harris, J., Halloran, B. P., Turner, R. T., Morey-Holton, E. R., & Bikle, D. D. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.1.21 · Cited by 119
The Unexplored Crossroads of the Female Athlete Triad and Iron Deficiency: A Narrative Review
Petkus, D. L., Murray-Kolb, L. E., & De Souza, M. J. (2017) · Sports Medicine · doi:10.1007/s40279-017-0706-2 · Cited by 92
Update in new anabolic therapies for osteoporosis
Canalis, E. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2677 · Cited by 85
Self-citationUnderstanding and managing corticosteroid-induced osteoporosis
Kobza, A. O., Herman, D., Papaioannou, A., Lau, A. N., & Adachi, J. D. (2021) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s282606 · Cited by 84
“Insulin-like growth factor 1 (IGF-1) promotes bone formation by stimulating type 1 collagen synthesis, suppressing bone collagen degradation and suppressing osteoblast apoptosis.(21) IGF-1 gene transcription is suppressed by glucocorticoids.”
BackgroundFuruya, Y., Inagaki, A., Khan, M., Mori, K., Penninger, J. M., Nakamura, M., Udagawa, N., Aoki, K., Ohya, K., Uchida, K., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.426080 · Cited by 77
“Bone formation is regulated by cytokines and factors inducing differentiation and mineralization of osteoblasts such as bone morphogenetic proteins (BMPs) (19), parathyroid hormone (PTH) (20), statins (21), Wingless-type (Wnt) (22), growth hormone (23), and insulin-like growth factor (IGF)-1 (24).”
BackgroundIGF-I induced phosphorylation of PTH receptor enhances osteoblast to osteocyte transition
Qiu, T., Crane, J. L., Xie, L., Xian, L., Xie, H., & Cao, X. (2018) · Bone Research · doi:10.1038/s41413-017-0002-7 · Cited by 59
Johansson, A. G., Baylink, D. J., af Ekenstam, E., Lindh, E., Mohan, S., & Ljunghall, S. (1994) · Bone and Mineral · doi:10.1016/s0169-6009(08)80128-6 · Cited by 45
Sex steroids and bone turnover markers in men with symptomatic vertebral fractures
Tuck, S. P., Scane, A. C., Fraser, W. D., Diver, M. J., Eastell, R., & Francis, R. M. (2008) · Bone · doi:10.1016/j.bone.2008.08.123 · Cited by 37
Bhattacharyya, R. S., & Stern, P. H. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10726 · Cited by 14
Metadata
- Authors
- Canalis, E., Centrella, M., Burch, W., & McCarthy, T. L.
- Venue
- Journal of Clinical Investigation
- Published
- 1989-01-01
- Volume
- 83
- Issue
- 1
- Pages
- 60-65
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2149726839
- Cited by
- 543
- References
- 24
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.